Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1886
https://www.valueinhealthjournal.com/article/S1098-3015(16)33252-1/fulltext
Title :
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type-2 Diabetes Mellitus in the UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33252-1&doi=10.1016/j.jval.2016.09.1886
First page :
A675
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1788